CannRX’s abstract has been accepted at the 2019 MJBizCon INT’L conference in Toronto, Canada. Dr. Bill Levine the Founder and Chief Scientific Officer of CannRX will deliver his presentation titled, “Development and Delivery: Science and New Technologies to Enhance Product Performance” on September 5 at 3:40 pm ET in Room 715.

The presentation is about the development of first-rate consistent cannabis products for medicinal and recreational use, from the extraction of ingredients to crafting of an optimized delivery system. Dr. Bill will also discuss the benefits of developing new technologies to facilitate the consistency of products.
MJBizCon INT’L begins on September 4th through 6th at the Metro Toronto Convention Center in Ontario. The event will feature 70 speakers and 150 exhibitors including the world’s leading cannabis experts.

About CannRX
CannRX, a subsidiary of Izun Pharmaceuticals, develops exclusive scientifically-based medical and recreational cannabis medical products. This company has developed proprietary formulations for sleep disorders and pain control. Other products the company is developing target Parkinson’s disease, oncology support, and sports industry recreation.